BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9800121)

  • 1. Retinoids in the chemoprevention of bladder cancer.
    Sabichi AL; Lerner SP; Grossman HB; Lippman SM
    Curr Opin Oncol; 1998 Sep; 10(5):479-84. PubMed ID: 9800121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
    Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
    Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of retinoids in the chemoprevention of cancer.
    de Palo G; Formelli F
    Drug Saf; 1995 Oct; 13(4):245-56. PubMed ID: 8573297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects.
    Tratnjek L; Jeruc J; Romih R; Zupančič D
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.
    Costa A; De Palo G; Decensi A; Formelli F; Chiesa F; Nava M; Camerini T; Marubini E; Veronesi U
    Ann N Y Acad Sci; 1995 Sep; 768():148-62. PubMed ID: 8526344
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoids and chemoprevention: clinical and basic studies.
    Lippman SM; Heyman RA; Kurie JM; Benner SE; Hong WK
    J Cell Biochem Suppl; 1995; 22():1-10. PubMed ID: 8538183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of carcinogenesis in the urinary bladder by retinoids.
    Hicks RM; Turton JA; Chowaniec J; Tomlinson CN; Gwynne J; Nandra K; Chrysostomou E; Pedrick M
    Ciba Found Symp; 1985; 113():168-90. PubMed ID: 3849405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.
    Torrisi R; Mezzetti M; Johansson H; Barreca A; Pigatto F; Robertson C; Decensi A
    Int J Cancer; 2000 Aug; 87(4):601-5. PubMed ID: 10918204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids in the prevention of bladder cancer.
    Nutting CM; Huddart RA
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and novel retinoids: their targets in cancer therapy.
    Fontana JA; Rishi AK
    Leukemia; 2002 Apr; 16(4):463-72. PubMed ID: 11960323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic.
    Ki Hong W; Lippman SM; Hittelman WN; Lotan R
    Clin Cancer Res; 1995 Jul; 1(7):677-86. PubMed ID: 9816032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids in bladder, testis and prostate cancer: epidemiologic, pre-clinical and clinical observations.
    Trump DL
    Leukemia; 1994; 8 Suppl 3():S50-4. PubMed ID: 7808025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids in chemoprevention of head and neck carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines.
    Zou C; Wang L; Liebert M; Grossman HB; Lotan R; Wei Q
    Int J Oncol; 1998 Nov; 13(5):1037-41. PubMed ID: 9772297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
    Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chemopreventive agents for bladder cancer.
    Kelloff GJ; Boone CW; Malone WF; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16I():1-12. PubMed ID: 1305671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.